Industry Applications
BostonGene’s AI-powered platform integrates molecular and immune profiling techniques to comprehensively analyze tumor, microenvironment, and host immunity. Benefit from fast, accurate results in a CLIA-certified, CAP-accredited, and New York State-approved environment. Save time and resources with BostonGene’s streamlined investigational process.